本文選題：慢性鼻-鼻竇炎　切入點(diǎn)：需氧菌　出處：《皖南醫(yī)學(xué)院》2016年碩士論文

【摘要】：目的:通過(guò)對(duì)慢性鼻-鼻竇炎(chronic rhinosinusitis,CRS)患者的鼻腔細(xì)菌培養(yǎng)及藥敏檢測(cè),了解本地區(qū)慢性鼻-鼻竇炎患者鼻腔需氧菌分布及藥物敏感性特點(diǎn),為本地區(qū)臨床抗菌藥物合理選擇提供依據(jù)。方法:在2010年1月1日至2015年12月31日期間,本地區(qū)慢性鼻-鼻竇炎患者中隨機(jī)選取181位患者行鼻腔需氧菌培養(yǎng)及藥物敏感試驗(yàn)。標(biāo)本在抗菌藥物使用前采集,常規(guī)消毒鼻前庭及鼻周皮膚,無(wú)菌前鼻鏡或鼻內(nèi)鏡輔助下,將無(wú)菌采樣拭子置入中鼻道,充分與中鼻道腫脹處黏膜及息肉組織接觸擦拭,旋轉(zhuǎn)拭子,留取黏膿性分泌物,在1小時(shí)內(nèi)送臨床檢驗(yàn)中心,行需氧菌分離培養(yǎng)以及藥物敏感試驗(yàn),根據(jù)藥敏報(bào)告指導(dǎo)臨床合理使用抗菌藥物。根據(jù)年齡特征將患者分為老年CRS患者組、中青年CRS患者組以及未成年CRS患者組。通過(guò)卡方檢驗(yàn)比較老年CRS組與中青年CRS組需氧菌培養(yǎng)報(bào)告陽(yáng)性率差異。結(jié)果:181例標(biāo)本中1例標(biāo)本培養(yǎng)2日未見細(xì)菌生長(zhǎng),其余180例(99.4%,180/181)標(biāo)本可見草綠色鏈球菌、奈瑟菌以及革蘭陽(yáng)性桿菌生長(zhǎng)(根據(jù)臨床上呼吸道微生物檢驗(yàn)陽(yáng)性報(bào)告標(biāo)準(zhǔn),這類細(xì)菌考慮為正常菌群)。臨床檢驗(yàn)中心共報(bào)告需氧菌18株,11個(gè)種類,陽(yáng)性率為9.9%(18/181)。革蘭陽(yáng)性需氧菌(Gram positive aerobes)10株(5.5%,10/181),其中最常見的菌株為金黃色葡萄球菌(3.3%,6/181);革蘭陰性需氧菌(Gram negative aerobes)8株(4.4%,8/181),最常見的菌株為產(chǎn)氣腸桿菌(1.7%,3/181),其余菌株均勻分布。老年CRS患者組30例標(biāo)本,報(bào)告陽(yáng)性率為16.7%(5/30),5株菌株均為革蘭陽(yáng)性菌,其中3株金黃色葡萄球菌比例最高(60%,3/5),余為肺炎鏈球菌及β-溶血A群鏈球菌各1株;中青年CRS患者組139例標(biāo)本,報(bào)告陽(yáng)性率為9.4%(13/139),革蘭陽(yáng)性菌5株,革蘭陰性菌8株,最常見的菌株為金黃色葡萄球菌以及產(chǎn)氣腸桿菌。未成年CRS組標(biāo)本均見上呼吸道正常微生物,無(wú)臨床檢驗(yàn)中心陽(yáng)性報(bào)告。經(jīng)卡方檢驗(yàn),中青年CRS患者組與老年CRS患者組報(bào)告陽(yáng)性率差異無(wú)統(tǒng)計(jì)學(xué)意義(?2=1.387,P=0.239,P0.05)。藥物敏感試驗(yàn)結(jié)果示中青年CRS患者組存在1株甲氧西林耐藥的表皮葡萄球菌(Methicillin resistant Staphylococcus epidermidis,MRSE)以及1株對(duì)第三代頭孢類抗菌素耐藥的革蘭陰性桿菌。2株甲氧西林耐藥的金黃色葡萄球菌(Methicillin resistant Staphylococcus aureus,MRSA)在中青年CRS患者組及老年CRS患者組各分布1株。MRSA在金黃色葡萄球菌中的比例為33.3%(2/6)。3株甲氧西林耐藥的葡萄球菌(Methicillin resistant Staphylococcus,MRS)對(duì)左氧氟沙星、達(dá)福普汀、利奈唑胺以及萬(wàn)古霉素均敏感�？傮w上氨芐西林、青霉素以及阿莫西林克拉維酸耐藥廣范。未見萬(wàn)古霉素、第四代頭孢菌素耐藥情況。結(jié)論:慢性鼻-鼻竇炎患者鼻腔需氧菌群以上呼吸道正常菌群為主,菌種廣泛,金黃色葡萄球菌、產(chǎn)氣腸桿菌最常見,其余菌種均勻分布。藥敏結(jié)果示氨芐西林、青霉素以及阿莫西林克拉維酸耐藥率高,左氧氟沙星抗菌活性好。本地區(qū)少數(shù)慢性鼻-鼻竇炎患者鼻腔存在MRS以及對(duì)第三代頭孢菌素耐藥的革蘭陰性桿菌,需加強(qiáng)院感監(jiān)測(cè)及防控。
[Abstract]:Objective: through for chronic rhinosinusitis (chronic rhinosinusitis, CRS) bacterial culture and drug sensitivity test in patients with nasal cavity, understand chronic nasal - local sinusitis distribution of aerobic bacteria and drug sensitivity characteristics of nasal cavity, selection of drugs provides a basis for the local antibiotic. Methods: in the period from January 1, 2010 to December 31, 2015, 181 patients the nasal cavity bacteria culture and drug sensitivity test were randomly selected for chronic nasal - local sinusitis patients. Specimens before acquisition of antimicrobial drugs, regular disinfection of nasal vestibule and nasal skin, aseptic before the nose or nasal endoscope, the sterile swab into the middle meatus, full and middle meatus mucosa swelling polyps and contact wipe, rotating swab specimens from sticky purulent secretions, send the clinical inspection center in 1 hours, for aerobic bacteria culture and drug sensitivity test, according to drug sensitivity Report to guide clinical rational use of antibiotics. According to the age characteristics of the patients were divided into elderly CRS patients, CRS patients and young adult patients with CRS group. By chi square test to compare the group of patients with CRS culture positive rate between the report and the young group CRS of aerobic bacteria. Results: 181 cases of the 1 specimens in culture 2, no bacterial growth, the remaining 180 cases (99.4%, 180/181) sample showed that Streptococcus viridans, Neisseria and gram positive bacillus growth (according to the clinical respiratory tract microbial test positive report standard, this type of bacteria is considered as normal flora). The clinical inspection center reported a total of 18 strains of aerobes and 11 species. The positive rate was 9.9% (18/181). Gram positive bacteria (Gram positive aerobes) 10 strains (5.5%, 10/181), one of the most common strains of Staphylococcus aureus (3.3%, 6/181); gram negative aerobic bacteria (Gram negative aerobes) 8 strains (4.4%, 8/181 ), the most common strains of Enterobacter aerogenes (1.7%, 3/181), others were evenly distributed. The elderly patients with CRS group of 30 specimens, the positive rate was 16.7% (5/30) report, 5 strains were gram positive bacteria, 3 strains of Staphylococcus aureus was the highest (60%, 3/5). More than for Streptococcus pneumoniae and beta hemolytic streptococcus A group 1 strain; young CRS patients 139 cases, the positive rate was 9.4% (13/139) report, 5 strains of gram positive bacteria, 8 strains of gram negative bacteria, the most common strains of Staphylococcus aureus and Enterobacter aerogenes minor. CRS groups see the upper respiratory tract of normal bacteria, no positive report of clinical inspection center. The chi square test, no statistically significant difference between the positive rate of CRS in young patients and elderly patients with CRS (2=1.387, P=0.239, report? P0.05). Drug sensitivity test results showed that CRS patients in the young group in 1 strains of methicillin the methicillin-resistant Staphylococcus epidermidis Bacteria (Methicillin resistant Staphylococcus epidermidis, MRSE) and 1 strains of the third generation cephalosporin antibiotic resistant gram negative bacillus.2 strains of methicillin resistant Staphylococcus aureus (Methicillin resistant Staphylococcus aureus, MRSA CRS) in young patients and elderly patients with CRS group distribution of 1 strains of.MRSA in Staphylococcus aureus was 33.3% in the (2/6).3 strains of methicillin resistant Staphylococcus aureus (Methicillin resistant, Staphylococcus, MRS) of levofloxacin, Dafoe, leptin, linezolid and vancomycin were sensitive to ampicillin. On the whole, penicillin and amoxicillin clavulanate. No vancomycin resistant wide, fourth generation cephalosporins. Conclusion: the nasal flora of upper respiratory tract normal flora, bacteria, Staphylococcus aureus, Enterobacter aerogenes The most common, other strains of uniform distribution. The results of drug sensitivity showed ampicillin, penicillin and amoxicillin clavulanic acid resistance rate is high, the antibacterial activity of levofloxacin nasal region. Few patients with chronic rhinosinusitis and MRS to the third generation cephalosporin resistant gram negative bacilli, the need to strengthen the hospital infection monitoring and control.

【學(xué)位授予單位】：皖南醫(yī)學(xué)院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R765.21;R765.41

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 李月;;臨床藥物敏感試驗(yàn)計(jì)時(shí)器的制作與應(yīng)用[J];護(hù)理研究;2009年31期

2 張建強(qiáng);;藥物敏感試驗(yàn)的現(xiàn)狀及臨床價(jià)值[J];工企醫(yī)刊;2009年06期

3 劉從森;胡小冬;管俊昌;;藥物敏感試驗(yàn)方法學(xué)概述[J];中國(guó)病原生物學(xué)雜志;2010年12期

4 高東哲;范若蘭;;結(jié)核菌藥物敏感試驗(yàn)及其在防治工作中的應(yīng)用[J];中國(guó)防癆通訊;1984年04期

5 劉增祥,張華;傷寒藥物敏感試驗(yàn)五十例及其療效分析[J];臨床薈萃;1987年06期

6 劉增祥,張華;傷寒藥物敏感試驗(yàn)50例及其療效分析[J];江蘇醫(yī)藥;1987年01期

7 趙必均,劉海水;1,844株臨床菌株的藥物敏感試驗(yàn)[J];中國(guó)醫(yī)院藥學(xué)雜志;1990年11期

8 魚達(dá);;抗癌藥物敏感試驗(yàn)前沿探實(shí)[J];浙江腫瘤通訊;1990年01期

9 魚達(dá);鄭樹;;抗癌藥物敏感試驗(yàn)近展[J];腫瘤防治研究;1991年01期

10 崔慶錄,郭秀蘭,冬青;布氏菌藥物敏感試驗(yàn)[J];中國(guó)地方病防治雜志;1992年05期

相關(guān)會(huì)議論文 前6條

1 答嶸;雷金娥;王偉;張凱歌;;59例臨床分離腦脊液細(xì)菌培養(yǎng)與藥物敏感試驗(yàn)結(jié)果的分析[A];中華醫(yī)學(xué)會(huì)第九次全國(guó)檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議暨中國(guó)醫(yī)院協(xié)會(huì)臨床檢驗(yàn)管理專業(yè)委員會(huì)第六屆全國(guó)臨床檢驗(yàn)實(shí)驗(yàn)室管理學(xué)術(shù)會(huì)議論文匯編[C];2011年

2 邰新榮;姚曉雄;范新春;;65例結(jié)核菌株藥物敏感試驗(yàn)結(jié)果分析[A];中國(guó)防癆協(xié)會(huì)全國(guó)學(xué)術(shù)會(huì)議大會(huì)學(xué)術(shù)報(bào)告[C];2001年

3 馬晨;答嶸;張凱歌;雷金娥;;417例臨床分離膽汁細(xì)菌培養(yǎng)與藥物敏感試驗(yàn)結(jié)果的分析[A];中華醫(yī)學(xué)會(huì)第七次全國(guó)中青年檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2012年

4 李忠泉;高崢;董松;焦月芝;董書魁;;1927例前列腺炎微生物培養(yǎng)結(jié)果及藥物敏感試驗(yàn)分析[A];第十屆全軍檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2005年

5 李保強(qiáng);段昕所;陸潔;于立勤;邢恩鴻;;泌尿生殖道感染病原學(xué)分析及支原體藥物敏感試驗(yàn)[A];中華醫(yī)學(xué)會(huì)第十五次全國(guó)皮膚性病學(xué)術(shù)會(huì)議論文集[C];2009年

6 潘韶霞;許磊;劉雨;張貴玲;吳芬;;深紅沙雷氏菌致肺感染一例報(bào)道[A];中華醫(yī)學(xué)會(huì)第八次全國(guó)檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議暨中華醫(yī)學(xué)會(huì)檢驗(yàn)分會(huì)成立30周年慶典大會(huì)資料匯編[C];2009年

相關(guān)重要報(bào)紙文章 前3條

1 四川省自貢市第三人民醫(yī)院主任醫(yī)師 劉勇;你了解PCT檢測(cè)嗎[N];健康報(bào);2014年

2 諸城綠安檢測(cè)有限公司 王潤(rùn)東 山東省畜牧獸醫(yī)職業(yè)學(xué)院 溫敬龍;如何才能找到對(duì)癥的藥？[N];中國(guó)畜牧獸醫(yī)報(bào);2006年

3 金慰鄂;“旅游瀉”用啥藥[N];醫(yī)藥經(jīng)濟(jì)報(bào);2002年

相關(guān)碩士學(xué)位論文 前1條

1 鳳璇;慢性鼻—鼻竇炎細(xì)菌培養(yǎng)及藥物敏感試驗(yàn)分析[D];皖南醫(yī)學(xué)院;2016年

，

本文編號(hào)：1716802